Full Text View
Tabular View
No Study Results Posted
Related Studies
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
This study has been completed.
Study NCT00182364   Information provided by McMaster University

First Received on September 10, 2005.   Last Updated on November 16, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critically Ill
Deep Venous Thrombosis
Additional conditions recognized in this trial
Critical Illness
Thromboembolism
Thrombosis
Venous Thromboembolism
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Disease Attributes
Embolism and Thrombosis
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
Calcium heparin
Dalteparin
Heparin
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)
Canadian Critical Care Trials Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services